Correlation Between Visa and LakeShore Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and LakeShore Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and LakeShore Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and LakeShore Biopharma Co,, you can compare the effects of market volatilities on Visa and LakeShore Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of LakeShore Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and LakeShore Biopharma.

Diversification Opportunities for Visa and LakeShore Biopharma

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Visa and LakeShore is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and LakeShore Biopharma Co, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LakeShore Biopharma Co, and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with LakeShore Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LakeShore Biopharma Co, has no effect on the direction of Visa i.e., Visa and LakeShore Biopharma go up and down completely randomly.

Pair Corralation between Visa and LakeShore Biopharma

Taking into account the 90-day investment horizon Visa is expected to generate 4.59 times less return on investment than LakeShore Biopharma. But when comparing it to its historical volatility, Visa Class A is 17.71 times less risky than LakeShore Biopharma. It trades about 0.08 of its potential returns per unit of risk. LakeShore Biopharma Co, is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  11.00  in LakeShore Biopharma Co, on August 24, 2024 and sell it today you would lose (7.00) from holding LakeShore Biopharma Co, or give up 63.64% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy17.78%
ValuesDaily Returns

Visa Class A  vs.  LakeShore Biopharma Co,

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.
LakeShore Biopharma Co, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days LakeShore Biopharma Co, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Visa and LakeShore Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and LakeShore Biopharma

The main advantage of trading using opposite Visa and LakeShore Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, LakeShore Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LakeShore Biopharma will offset losses from the drop in LakeShore Biopharma's long position.
The idea behind Visa Class A and LakeShore Biopharma Co, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities